Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Deoxyguanosine Kinase anticorps (N-Term)

DGUOK Reactivité: Humain, Souris WB Hôte: Lapin Polyclonal RB5277 unconjugated
N° du produit ABIN391122
  • Antigène Voir toutes Deoxyguanosine Kinase (DGUOK) Anticorps
    Deoxyguanosine Kinase (DGUOK)
    Épitope
    • 7
    • 6
    • 6
    • 4
    • 2
    • 1
    • 1
    AA 1-30, N-Term
    Reactivité
    • 29
    • 8
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 27
    • 2
    Lapin
    Clonalité
    • 27
    • 2
    Polyclonal
    Conjugué
    • 15
    • 4
    • 3
    • 3
    • 2
    • 2
    Cet anticorp Deoxyguanosine Kinase est non-conjugé
    Application
    • 22
    • 22
    • 4
    • 1
    • 1
    Western Blotting (WB)
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogène
    This Deoxyguanosine Kinase (DGUOK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human Deoxyguanosine Kinase (DGUOK).
    Clone
    RB5277
    Isotype
    Ig Fraction
    Top Product
    Discover our top product DGUOK Anticorps primaire
  • Indications d'application
    WB: 1:1000. WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Antigène
    Deoxyguanosine Kinase (DGUOK)
    Abstract
    DGUOK Produits
    Synonymes
    anticorps DGUOK, anticorps zgc:86625, anticorps dgk, anticorps DDBDRAFT_0218264, anticorps DDBDRAFT_0233982, anticorps DDB_0218264, anticorps DDB_0233982, anticorps MTDPS3, anticorps dGK, anticorps dGK1, anticorps dGK2, anticorps dGK3, anticorps deoxyguanosine kinase, anticorps deoxyguanosine kinase L homeolog, anticorps DGUOK, anticorps dguok, anticorps dguok.L, anticorps dgk, anticorps Ccan_04750, anticorps Dguok
    Sujet
    Mitochondrial deoxyguanosine kinase (DGUOK) is required for the phosphorylation of several deoxyribonucleosides and certain purine deoxykribonucleoside analogs widely employed as antiviral and chemotherapeutic agents. Purine deoxyribonucleoside analogs are extensively used in treatment of lymphoproliferative disorders. These compounds are administered as pro-drugs, and their efficiency is dependent on intracellular phosphorylation to the corresponding triphosphates. In mammalian cells, the phosphorylation of purine deoxyribonucleosides is mediated predominantly by 2 deoxyribonucleoside kinases: cytosolic deoxycytidine kinase (DCK) and mitochondrial deoxyguanosine kinase (DGUOK also known as DGK). DGUOK expression is ubiquitous, with highest levels in muscle, brain, liver and lymphoid tissues. Defects in DGUOK are a cause of mitochondrial DNA depletion syndrome (MDS). MDS is a clinically heterogeneous group of disorders characterized by a reduction in mitochondrial DNA (mtDNA) copy number. Primary mtDNA depletion is inherited as an autosomal recessive trait and may affect single organs, typically muscle or liver, or multiple tissues. Mitochondrial DNA depletion syndromes are phenotypically heterogeneous, autosomal recessive disorders characterized by tissue-specific reduction in mtDNA copy number. Affected individuals with the hepatocerebral form of mtDNA depletion syndrome have early progressive liver failure and neurologic abnormalities, hypoglycemia, and increased lactate in body fluids.
    Poids moléculaire
    32056
    ID gène
    1716
    NCBI Accession
    NP_550438, NP_550440
    UniProt
    Q16854
    Pathways
    Ribonucleoside Biosynthetic Process
Vous êtes ici:
Support technique